KGW-TV profiles Rhonda Stranz, a patient with advanced breast cancer who has shown signs of improvement after enrolling in a Phase I clinical trial at OHSU. Stranz says: "Once I started taking the clinical trial medicine, everything just immediately started changing back to normal. Every day is a blessing, being out here every day. I’m still out here and I’m healthy and I’m feeling good. I don’t feel like I have cancer.”

Atul Deodhar, M.D., presented on the disease manifestations and epidemiology or SpondyloArhritis at the 19th Annual Johns Hopkins Advances in the Diagnosis and Treatment of the Rheumatic Diseases Symposium.

Becker's Hospital CFO report notes Legacy Health has been downgraded from "A" to "A-" in S& P Global. "A strong enterprise profile and a planned merger with Portland-based Oregon Health & Science University continues to help shore up the overall rating," S&P Global stressed.

Additional coverage from the Doernbecher Freestyle XIX new collections designed by six young OHSU patients.

Chris Slatore, M.D., highlights National Lung Cancer Screening Day coinciding with Veteran’s Day, emphasizing the VA's commitment to delivering best-in-class care to veterans: “In 2022, lung cancer took over 130,000 Americans from us, and 8,000 veterans every year are served by the VA who have lung cancer. Those are just not numbers, those are real people.”

OPB-Radio’s Think Out Loud notes that ground-level falls are now the single most common source of trauma treated at OHSU Hospital. Katie Drago, M.D., calls it a “growing public health emergency,” but there are steps that older adults and families can take to minimize the risk of traumatic falls. In an OHSU News story, Mackenzie Cook, M.D., says: “These are life-changing injuries. I’ve seen people who have died from injuries like this.”

Medical News Today covers a recent publication by Erick Turner, M.D., which reveals a common sedative may be less effective than generally believed.

Additional coverage from the Doernbecher Freestyle XIX new collections designed by six young OHSU patients.

The New York Post profiles OHSU patient Amber Pearson who is the first in the world to benefit from a single stimulator implanted in the brain to effectively control two life-altering conditions: seizures caused by epilepsy and compulsive behavior caused by obsessive-compulsive disorder. Pearson says: "It wasn’t instantaneous. It took a few months to notice changes. I slowly started noticing things disappearing from my routine. Then, more things would disappear.”

PR Newswire release from RaySearch Laboratories AB announces that OHSU has placed an order for a RayStation treatment planning system. John Bayouth, Ph.D., says, “OHSU is building the organization’s technological platforms for advance radiation therapy.”